Standard versus low-dose nab-paclitaxel in previously treated patients with advanced non-small cell lung cancer: A randomized phase II trial (JMTO LC14-01).

Susumu TakeuchiKaoru KubotaShunichi SugawaraSatoshi TeramukaiRintaro NoroKei FujikawaTakashi HiroseShinji AtagiSeigo MinamiShinichiro IidaHiroshi KuraishiTomoiki AibaYuji MinegishiMasaru MatsumotoMasahiro SeikeAkihiko GemmaMasaaki Kawaharanull null

Published in: Cancer medicine (2023)

dose and schedule in the trial would be a reasonable option.

Keyphrases

advanced non small cell lung cancer
low dose
epidermal growth factor receptor
phase iii
open label
study protocol
phase ii
high dose
clinical trial
simultaneous determination
placebo controlled
liquid chromatography